BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 622540)

  • 1. [Diagnosis and therapy of chronic active hepatitis].
    Paumgartner G
    Schweiz Med Wochenschr; 1978 Jan; 108(4):120-3. PubMed ID: 622540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
    Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
    Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic active hepatitis--present state. The pros and cons of immunosuppressive therapy.
    Thaler H
    Hepatogastroenterology; 1984 Feb; 31(1):6-11. PubMed ID: 6698488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of chronic hepatitis (author's transl)].
    Arnold W; Meyer zum Büschenfelde KH
    Leber Magen Darm; 1981 Apr; 11(2):73-80. PubMed ID: 6164895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of chronic hepatitis. Results of a retrospective study.
    Thaler H
    Tokai J Exp Clin Med; 1980 Jul; 5(3):361-6. PubMed ID: 7222126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive long-term treatment of chronic aggressive hepatitis].
    Schimmelpfennig W; Schneider G; Wagner K; Wack R; Lunzenauer K
    Z Gesamte Inn Med; 1975 Dec; 30(24):273 concl. PubMed ID: 1221650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A; Paál M; Kádas I; Kerekes E; Jávor T
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic HB virus hepatitis in children. A study of 29 cases].
    Maggiore G; Marzani D; De Giacomo C; Sessa F; Civardi G; Scotta MS
    Sem Hop; 1984 May; 60(19):1349-52. PubMed ID: 6326326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic reactivity of the skin in chronic hepatitis].
    Fuchs H
    Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment of the early stages of active or inactive chronic hepatitis: results of a pilot study (author's transl)].
    Vido I; Ranft U; Schmidt FW
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1411-4. PubMed ID: 7449642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of different types of treatments in chronic active hepatitis.
    Bahgat MH; Sabbour MS; Osman LM; Ghali AF; Gadallah MA
    Chemioterapia; 1985 Jun; 4(3):227-35. PubMed ID: 2411437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of chronic hepatitis (author's transl)].
    Auer IO
    Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
    Mansurov KhKh; Mirodzhov GK; Mishanina ZG; Pavlov VL
    Ter Arkh; 1985; 57(2):77-80. PubMed ID: 3890253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamics of chronic active hepatitis with varying degrees of severity].
    Serov VV; Aprosina ZG; Popov MS; Popova IV; Tikhonova GN
    Arkh Patol; 1981; 43(8):12-27. PubMed ID: 6457594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic active hepatitis.
    Donovan EJ
    Rocky Mt Med J; 1972 Feb; 69(2):62-6. PubMed ID: 5007769
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.